In October 2024, CorTec received both FDA Investigational Device Exemption and IRB approval from the University of Washington, clearing the path for the first-ever human implantation of a fully implantable, German-developed Brain-Computer Interface system. The study, conducted in collaboration with researchers from the University of Washington and UCLA, targets motor recovery in stroke patients with arm paralysis.
